Subsequently, survival analysis and differential expression analysis among various major stages demonstrated that only high expression of pseudogene DUXAP8 and DUXAP9 indicated poor OS and RFS in ccRCC, chRCC and pRCC. This evidence concerns the gene DUXAP8 and nonpapillary renal cell carcinoma.